Not applicableUnknownNCT03815864What this trial is testingAntibodies and Liver RetransplantationWho this might be right forLiver Transplant FailureAntibody-mediated Rejection London Health Sciences Centre 200
Testing effectiveness (Phase 2)Study completedNCT00005940What this trial is testingRadiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First RemissionWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT01134510What this trial is testingSafety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent RejectionWho this might be right forKidney Transplantation Stanley Jordan, MD 20
Not applicableStudy completedNCT03423901What this trial is testingImpact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney TransplantationWho this might be right forKidney Transplant University Hospital, Toulouse 58
Not applicableEnded earlyNCT02115503What this trial is testingA Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft RecipientsWho this might be right forRenal Transplant Recipients With Anti-HLA Antibodies Databean 52
Not applicableActive Not RecruitingNCT07316829What this trial is testingTRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiSWho this might be right forGraft RejectionKidney TransplantationLung Transplantation+6 more Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableUnknownNCT05282875What this trial is testingAnti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to DialysisWho this might be right forKidney TransplantationImmunosuppressive AgentsHLA Sensitization+1 more Central Hospital, Nancy, France 430
Testing effectiveness (Phase 2)Study completedNCT03380377What this trial is testingClazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney TransplantWho this might be right forAntibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more Stanley Jordan, MD 10
Testing effectiveness (Phase 2)WithdrawnNCT04174677What this trial is testingSafety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased DonorWho this might be right forHighly Sensitized Patients on Waiting List for Kidney Transplantation Amgen
Not applicableNot Yet RecruitingNCT06774365What this trial is testingCARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart TransplantationWho this might be right forHeart TransplantationRejection Heart TransplantHLA Antigens IRCCS Azienda Ospedaliero-Universitaria di Bologna 683
Early research (Phase 1)Study completedNCT01503242What this trial is testing90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple MyelomaWho this might be right forPlasma Cell MyelomaRefractory Plasma Cell Myeloma Fred Hutchinson Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00090194What this trial is testingImproving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%Who this might be right forKidney Failure, Chronic National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableUnknownNCT06013358What this trial is testingDdcfDNA in Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Seoul National University Hospital 200
Not applicableStudy completedNCT03438058What this trial is testingComplement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ TransplantationWho this might be right forOrgan Transplant Recipients Paris Translational Research Center for Organ Transplantation 7,547
Testing effectiveness (Phase 2)Looking for participantsNCT06380816What this trial is testingA Phase I/II Trial of UCB4594 in Participants With Advanced CancerWho this might be right forAdvanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more Cancer Research UK 167
Not applicableStudy completedNCT06040684What this trial is testingDevelopment of Antibodies Against Transplant Kidney After InfectionWho this might be right forAcute InfectionKidney Failure University Hospital Ostrava 30
Not applicableUnknownNCT03861962What this trial is testingRe-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope LevelWho this might be right forOrgan Transplantation Assistance Publique - Hôpitaux de Paris 20,000
Testing effectiveness (Phase 2)Study completedNCT02738918What this trial is testingBelatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.Who this might be right forRenal TransplantAcute Antibody Mediated RejectionMild Immunologic Risk Factor Assistance Publique - Hôpitaux de Paris 51
Not applicableLooking for participantsNCT06025240What this trial is testingExpanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant RecipientsWho this might be right forKidney TransplantRenal Transplant FailureKidney Transplant Rejection+5 more Liverpool University Hospitals NHS Foundation Trust 282
Not applicableStudy completedNCT07200583What this trial is testingProtein A Immunoadsorption in Highly Sensitized Haplo-HSCT PatientsWho this might be right forHematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more Ting YANG 50